Computational Modeling of Small Molecule Ligand Binding Interactions and Affinities.
暂无分享,去创建一个
[1] J A McCammon,et al. Accommodating protein flexibility in computational drug design. , 2000, Molecular pharmacology.
[2] Stefan Wallin,et al. Exploring Protein-Peptide Binding Specificity through Computational Peptide Screening , 2013, PLoS Comput. Biol..
[3] Pradeep Kota,et al. Automated minimization of steric clashes in protein structures , 2011, Proteins.
[4] T. Halgren. Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94 , 1996, J. Comput. Chem..
[5] Ruben Abagyan,et al. Consistent Improvement of Cross-Docking Results Using Binding Site Ensembles Generated with Elastic Network Normal Modes , 2009, J. Chem. Inf. Model..
[6] X. Barril,et al. Unveiling the full potential of flexible receptor docking using multiple crystallographic structures. , 2005, Journal of medicinal chemistry.
[7] M. Karplus,et al. Molecular dynamics and protein function. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[8] Nikolay V. Dokholyan,et al. MedusaScore: An Accurate Force Field-Based Scoring Function for Virtual Drug Screening , 2008, J. Chem. Inf. Model..
[9] Joseph Audie,et al. Recent work in the development and application of protein-peptide docking. , 2012, Future medicinal chemistry.
[10] Xiaoqin Zou,et al. Challenges, Applications, and Recent Advances of Protein-Ligand Docking in Structure-Based Drug Design , 2014, Molecules.
[11] Pedro Alexandrino Fernandes,et al. Protein–ligand docking: Current status and future challenges , 2006, Proteins.
[12] Kevin M. D'Auria,et al. Structural and dynamic determinants of protein-peptide recognition. , 2011, Structure.
[13] Heather A Carlson,et al. Exploring experimental sources of multiple protein conformations in structure-based drug design. , 2007, Journal of the American Chemical Society.
[14] W. L. Jorgensen,et al. The OPLS [optimized potentials for liquid simulations] potential functions for proteins, energy minimizations for crystals of cyclic peptides and crambin. , 1988, Journal of the American Chemical Society.
[15] S. Teague. Implications of protein flexibility for drug discovery , 2003, Nature Reviews Drug Discovery.
[16] Martin Karplus,et al. Molecular dynamics of biological macromolecules: A brief history and perspective , 2003, Biopolymers.
[17] C. C. Heyde,et al. Central Limit Theorem , 2006 .
[18] T. N. Bhat,et al. The Protein Data Bank , 2000, Nucleic Acids Res..
[19] Feng Ding,et al. Incorporating Backbone Flexibility in MedusaDock Improves Ligand-Binding Pose Prediction in the CSAR2011 Docking Benchmark , 2013, J. Chem. Inf. Model..
[20] Brian K Shoichet,et al. Prediction of protein-ligand interactions. Docking and scoring: successes and gaps. , 2006, Journal of medicinal chemistry.
[21] Feng Ding,et al. Rapid Flexible Docking Using a Stochastic Rotamer Library of Ligands , 2010, J. Chem. Inf. Model..
[22] Adrian W. R. Serohijos,et al. Structural basis for μ-opioid receptor binding and activation. , 2011, Structure.
[23] T. A. Jones,et al. The Uppsala Electron-Density Server. , 2004, Acta crystallographica. Section D, Biological crystallography.
[24] A. Tropsha,et al. Beware of q 2 , 2002 .
[25] Pradeep Kota,et al. Gaia: automated quality assessment of protein structure models , 2011, Bioinform..
[26] Thomas A. Halgren. Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94 , 1996, J. Comput. Chem..
[27] R. Abagyan,et al. Conserved binding mode of human beta2 adrenergic receptor inverse agonists and antagonist revealed by X-ray crystallography. , 2010, Journal of the American Chemical Society.
[28] B. X. Carlson,et al. A single glycine residue at the entrance to the first membrane-spanning domain of the gamma-aminobutyric acid type A receptor beta(2) subunit affects allosteric sensitivity to GABA and anesthetics. , 2000, Molecular pharmacology.
[29] M L Teodoro,et al. Conformational flexibility models for the receptor in structure based drug design. , 2003, Current pharmaceutical design.
[30] A. Tropsha,et al. Beware of q2! , 2002, Journal of molecular graphics & modelling.
[31] W. L. Jorgensen,et al. Development and Testing of the OPLS All-Atom Force Field on Conformational Energetics and Properties of Organic Liquids , 1996 .
[32] L. Dardenne,et al. Receptor–ligand molecular docking , 2013, Biophysical Reviews.
[33] L. Kelley,et al. An automated approach for clustering an ensemble of NMR-derived protein structures into conformationally related subfamilies. , 1996, Protein engineering.
[34] G. Klebe,et al. Statistical potentials and scoring functions applied to protein-ligand binding. , 2001, Current opinion in structural biology.